2019 Tevlin Women's Challenger – Singles
Quirine Lemoine was the defending champion, but chose not to participate.[1]
Singles | |
---|---|
2019 Tevlin Women's Challenger | |
Champion | |
Runner-up | |
Final score | 7–6(7–3), 6–4 |
Francesca Di Lorenzo won the title, defeating Kirsten Flipkens in the final, 7–6(7–3), 6–4.
Seeds
Kirsten Flipkens (Final) Francesca Di Lorenzo (Champion) Bibiane Schoofs (Semifinals) Sachia Vickery (First round) Robin Anderson (First round) Jessika Ponchet (Quarterfinals) Elitsa Kostova (Quarterfinals) Jovana Jakšić (First round)
Draw
Key
- Q = Qualifier
- WC = Wild Card
- LL = Lucky Loser
- Alt = Alternate
- SE = Special Exempt
- PR = Protected Ranking
- ITF = ITF entry
- JE = Junior Exempt
- w/o = Walkover
- r = Retired
- d = Defaulted
Finals
Semifinals | Final | ||||||||||||
1 | 2 | 6 | 6 | ||||||||||
6 | 2 | 3 | |||||||||||
1 | 63 | 4 | |||||||||||
2 | 77 | 6 | |||||||||||
3 | 5 | 6 | 2 | ||||||||||
2 | 7 | 0 | 6 | ||||||||||
Top half
First Round | Second Round | Quarterfinals | Semifinals | ||||||||||||||||||||||||
1 | 6 | 6 | |||||||||||||||||||||||||
WC | 2 | 1 | 1 | 6 | 6 | ||||||||||||||||||||||
6 | 65 | 6 | 2 | 2 | |||||||||||||||||||||||
Q | 3 | 77 | 1 | 1 | 6 | 6 | |||||||||||||||||||||
Q | 6 | 6 | 7 | 3 | 2 | ||||||||||||||||||||||
Q | 3 | 3 | Q | 3 | 3 | ||||||||||||||||||||||
WC | 2 | 6 | 1 | 7 | 6 | 6 | |||||||||||||||||||||
7 | 6 | 4 | 6 | 1 | 2 | 6 | 6 | ||||||||||||||||||||
4 | 3 | 3 | 6 | 2 | 3 | ||||||||||||||||||||||
WC | 6 | 6 | WC | 2 | 0r | ||||||||||||||||||||||
Q | 4 | 5 | 6 | 0 | |||||||||||||||||||||||
6 | 7 | 5 | 6 | 1 | |||||||||||||||||||||||
2 | 4 | 7 | 3 | 6 | |||||||||||||||||||||||
6 | 6 | 7 | 7 | ||||||||||||||||||||||||
Q | 1 | 77 | 7 | Q | 5 | 5 | |||||||||||||||||||||
8 | 6 | 64 | 5 |
Bottom half
First Round | Second Round | Quarterfinals | Semifinals | ||||||||||||||||||||||||
6 | 6 | 77 | |||||||||||||||||||||||||
1 | 64 | 6 | 6 | 77 | |||||||||||||||||||||||
65 | 2 | WC | 3 | 63 | |||||||||||||||||||||||
WC | 77 | 6 | 6 | 4 | 4 | ||||||||||||||||||||||
3 | 0 | 3 | 6 | 6 | |||||||||||||||||||||||
6 | 6 | 77 | 1 | 0 | |||||||||||||||||||||||
6 | 5 | 4 | 3 | 65 | 6 | 6 | |||||||||||||||||||||
3 | 2 | 7 | 6 | 3 | 5 | 6 | 2 | ||||||||||||||||||||
5 | 6 | 64 | 5 | 2 | 7 | 0 | 6 | ||||||||||||||||||||
1 | 77 | 7 | 6 | 6 | |||||||||||||||||||||||
Q | 6 | 2 | 7 | Q | 4 | 1 | |||||||||||||||||||||
Q | 3 | 6 | 5 | 79 | 1 | 4 | |||||||||||||||||||||
6 | 64 | 77 | 2 | 67 | 6 | 6 | |||||||||||||||||||||
4 | 77 | 61 | 4 | 6 | 3 | ||||||||||||||||||||||
Q | 66 | 4 | 2 | 6 | 2 | 6 | |||||||||||||||||||||
2 | 78 | 6 |
gollark: I think so. IIRC the mutations mostly didn't affect the stuff vaccines targeted, but I didn't pay much attention.
gollark: "Ah yes, I will voluntarily ask for less pay" - nobody?
gollark: Seems more like a publicity stunt than anything useful.
gollark: As far as I'm aware, it has not been remotely rigorously tested and has only gone through two months of human trials.
gollark: … maybe? Even if they have a working, safe and effective vaccine, which seems somewhat dubious given that there are still lots of trials going on here, it'll still take a while for production and distribution.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.